SCHEMBL23183455

SCHEMBL23183455

CSc1[nH]c(=O)cc(-c2ccccc2)c1C#N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.54
▸ ALDH1A1 P00352 11/20 0.52
▸ KDM4E B2RXH2 8/20 0.52
▸ KMT2A Q03164 5/20 0.52
▸ RXFP1 Q9HBX9 3/20 0.52
▸ HPGD P15428 6/20 0.49
▸ GAA P10253 2/20 0.49
▸ GALR3 O60755 1/20 0.49
▸ PPARG P37231 1/20 0.48
▸ NCOR2 Q9Y618 1/20 0.48
▸ PIM1 P11309 3/20 0.47
▸ BIRC5 O15392 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20350807 0.85 ATM (0.54) ATMALDH1A1KDM4EKMT2ARXFP1
SCHEMBL20339939 0.79 KMT2A (0.62) ATMALDH1A1KDM4EKMT2AHPGD
SCHEMBL23183523 0.77 KDM4E (0.58) ALDH1A1KDM4EKMT2ARXFP1HPGD
SCHEMBL20339404 0.76 ATM (0.58) ATMALDH1A1KDM4EKMT2ARXFP1
SCHEMBL26847198 0.76 KMT2A (0.45) ATMALDH1A1KDM4EKMT2AHPGD
SCHEMBL20350920 0.75 PIM1 (0.48) ATMALDH1A1KDM4EKMT2AHPGD
SCHEMBL20351074 0.74 ATM (0.40) ATMALDH1A1KDM4EKMT2ARXFP1
SCHEMBL20350878 0.72 ATM (0.39) ATMALDH1A1KDM4EKMT2ARXFP1
SCHEMBL6193017 0.72 ATM (0.69) ATMALDH1A1KDM4EKMT2ARXFP1
SCHEMBL23183409 0.72 ALDH1A1 (0.41) ALDH1A1KDM4EKMT2ARXFP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ORSOBIO, INC. 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ALDH7A1, OTC, DDC ATM 2266/4885ALDH1A1 417/4885KDM4E 1198/4885
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 ATM 2021/4885ALDH1A1 370/4885KDM4E 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback